Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 60 days ( 0 % )
Last Price $0.660 0 %
High/ Low $0.660 - $0.660 0%
Chg 7 Days N/A $0.660 $0.660
Chg 30 Days N/A $0.660 $0.660
Chg 12 mos -70.27 % $2.22 $0.660
Trend - 3 mos -1.68 % Width: 22.29 %
Trend - 12 mos -41.44 % Width: 2,314.78 %
Pred. range - 3 mos $0.636 - $0.778 -3.66 % - 17.81 %
Pred. range - 12 mos $0.0234 - $0.564 -96.46 % - -14.52 %
Short MA avg 3 mos Sell 0000-00-00 - N/A days
Long MA avg 3 mos Sell 0000-00-00 - N/A days
Short/Long MA avg 3 mos Sell 0000-00-00 - N/A days
Short MA avg 12 mos Sell 2023-11-13 - 66 days
Long MA avg 12 mos Sell 2023-11-13 - 66 days
Short/Long MA avg 12 mos Sell 2023-11-22 - 59 days
Pivot Short Buy 2023-11-20 - 61 days
Bollinger Sell 0000-00-00 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Acer Therapeutics Inc.

Acer Therapeutics. Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mutation; ACER-001, a formulation of sodium phenylbutyrate for the treatment of various inborn errors of ... ACER Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT